The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 347:966-967 September 26, 2002 Number 13
NextNext

Treating Sepsis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Warren, H. S.
-Related Article
 by Siegel, J. P.
-Related Article
 by Manns, B. J.
-PubMed Citation
Sepsis, a leading cause of death in the United States, is now viewed physiologically as a proinflammatory and procoagulant response to invading pathogens. There are three recognized stages in the hierarchy of the inflammatory response, with progressively increased risk of end-organ failure and death: sepsis, severe sepsis, and septic shock. Patients with infection plus two or more elements of the systemic inflammatory response syndrome meet the criteria for sepsis; those who also have end-organ failure are considered to have severe sepsis; and those who also have refractory hypotension are considered to be in septic shock (see Figure). Because the . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.